934765-85-2Relevant academic research and scientific papers
As opioid receptor antagonists or inverse agonists of the novel compounds
-
Paragraph 0252; 0253, (2016/10/08)
Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.
NOVEL HETEROCYCLE COMPOUNDS
-
Page/Page column 46, (2009/04/24)
The present invention relates to novel compounds which are antagonist or inverse agonists at an opioid receptor. Such compounds are useful in the treatment of obesity and related diseases and/or conditions in mammals, particularly humans. Methods of making and using such compounds are also disclosed.
